How does a BioPharma Cluster ascend the ranks to secure a Top 3 position? What are the key factors propelling the BioHealth Capital Region to achieve its ambitious goal of ranking 3rd by 2023? Join us in this episode of BioTalk, where our host Rich Bendis speaks with Alex Philippidis, Senior Business Editor at Genetic Engineering & Biotechnology News.
In this installment, Alex unveils the intricacies behind his latest Top 10 U.S. Biopharma Clusters, highlighting the impressive rise of the BioHealth Capital Region to its 3rd position. Learn about the origins of these rankings, the trends that have been identified for 2023, and the dynamic shifts within the BioPharma landscape on a regional scale.
Listen now via your favorite podcasting platform:
- Apple: https://apple.co/45tT5nJ
- Google: https://bit.ly/3qzcnJC
- Spotify: https://spoti.fi/3scEUW4
- Amazon Music: https://amzn.to/3s6OKZn
- TuneIn: https://bit.ly/3OtbQku
- YouTube Audio: https://bit.ly/3OzmtlZ
Alex Philippidis | Senior Business Editor | @alexwestchester
Alex specializes in biopharma business news and industry issues for GEN. He joined GEN in 2011 after four years at GenomeWeb, where he covered research institutes, and spent three years following biotech economic development as editor of the weekly newsletter BioRegion News. Alex reports a variety of news stories for GEN and Clinical OMICs and compiles the popular A-Lists series.
Alex previously worked for more than 20 years for various newspapers covering business, science, the Navy, and general-interest news. He has been interviewed and quoted by news outlets including the New York Times and the BBC. He enjoys solving crossword puzzles, watching classic TV game shows, and traveling with his family.